2012
DOI: 10.1074/jbc.m111.302380
|View full text |Cite
|
Sign up to set email alerts
|

Sphingosine 1-Phosphate (S1P) Lyase Deficiency Increases Sphingolipid Formation via Recycling at the Expense of de Novo Biosynthesis in Neurons

Abstract: Background: Knock-out of S1P lyase, the only enzyme cleaving the sphingoid backbone, causes a severe phenotype. Results: S1P lyase deficiency affects sphingolipid and cholesterol metabolism and also expression of Orm1/3 proteins. Conclusion: Accumulation of free and phosphorylated sphingoid bases by loss of S1P lyase causes readjustment of the balance between de novo biosynthesis and recycling to maintain (glyco)sphingolipid homeostasis. Significance: Data provide the first evidence for a mechanism that enable… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
42
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 47 publications
(44 citation statements)
references
References 40 publications
(50 reference statements)
1
42
0
1
Order By: Relevance
“…This result indicates that sphingadienine can be metabolized to ceramide in intestinal cells during absorption. As phosphorylation followed by dephosphorylation is required for the incorporation of exogenous sphingoid bases into complex sphingolipids (33,34), 4t,8c-sphingadienene should be phosphorylated by sphingosine kinase after uptake by intestinal cells.…”
Section: Discussionmentioning
confidence: 99%
“…This result indicates that sphingadienine can be metabolized to ceramide in intestinal cells during absorption. As phosphorylation followed by dephosphorylation is required for the incorporation of exogenous sphingoid bases into complex sphingolipids (33,34), 4t,8c-sphingadienene should be phosphorylated by sphingosine kinase after uptake by intestinal cells.…”
Section: Discussionmentioning
confidence: 99%
“…4). Notably, the effect of S1PL deficiency on sphingolipid metabolism in neurons and cholesterol levels in the brain was rather slight when compared with that in liver and serum [69,73]. Thus, no significant changes of the content of ceramide, sphingomyelin and of glycosphingolipids in neurons could be detected [69].…”
Section: S1p - a Potential Mediator In The Pathogenesis Of Alzheimer'mentioning
confidence: 99%
“…As depicted above, growing evidence indicates that S1P, a bioactive catabolic intermediate of all sphingolipids might represent a potential link between ganglioside metabolism and neurodegeneration. Neuronal levels of S1P are tightly regulated at very low concentrations in the picomolar range [18,69]. A direct role of S1P in neuronal Aβ generation has been reported recently [23].…”
Section: S1p - a Potential Mediator In The Pathogenesis Of Alzheimer'mentioning
confidence: 99%
“…Also, cerebellar neurons derived from S1PL-KO mice, which have 20-fold increased concentrations of intracellular S1P, are more susceptible to certain stressors and undergo early cell death (23)(24)(25). Deficiency of S1P-lyase is also associated with elevated levels of basal intracellular Ca 2ϩ concentrations and increased stimulated Ca 2ϩ release from intracellular stores (25,26).…”
mentioning
confidence: 99%